se of heparin to prevent lung microvascular thrombosis in patients administered aprotinin undergoing cardiac surgery for ischemic heart disease

Phase 2

• Conditions: Ischaemic heart disease; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12606000328572
• Lead Sponsor: St. Vincents Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Elective cardiac surgery.

Exclusion Criteria

Repeat cardiac surgery , complex surgery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evidence of microvascular thrombosis on lung biopsy[Taken at the end of cardiac surgery]

Secondary Outcome Measures

Name	Time	Method
Alveolar dead space [Meausured at induction and at the end of cardiac surgery.]